India  

Biophore seeks EUA from DCGI for Aviptadil inhalation for Covid-19 treatment

IndiaTimes Friday, 11 June 2021 ()
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Emergency Use Authorization Granted by the Food and Drug Administration in the US

Ocugen to seek full approval for Covaxin in US via BLA instead of EUA

Bharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be..
IndiaTimes

Ocugen to take BLA route for Covaxin in US based on FDA recommendation; seek emergency use nod for Canada

Bharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be..
IndiaTimes
J&J'S vaccine pause should be lifted -CDC advisers [Video]

J&J'S vaccine pause should be lifted -CDC advisers

Use of Johnson & Johnson's COVID-19 vaccine should be resumed in the United States, advisers to U.S. health regulators said on Friday, after weighing evidence of the shot's link to extremely rare but potentially deadly blood clots. Lisa Bernhard produced this report.

Credit: Reuters - Politics    Duration: 01:50Published

Drugs Controller General of India Drugs Controller General of India

Gautam Gambhir Foundation guilty of hoarding FabiFlu Covid vaccine: DGCA| Delhi HC | Oneindia News [Video]

Gautam Gambhir Foundation guilty of hoarding FabiFlu Covid vaccine: DGCA| Delhi HC | Oneindia News

The Drugs Controller General of India has found the Gautam Gambhir Foundation guilty of stocking, procuring and distributing Fabiflu medicine in an unaurthorised manner to the COVID-19 patients, the Delhi High Court was informed on Thursday. #GautamGambhir #DCGA #FabiFlu

Credit: Oneindia    Duration: 01:45Published
Pfizer and Moderna vaccines may arrive in India soon| DCGI paves the way | Oneindia News [Video]

Pfizer and Moderna vaccines may arrive in India soon| DCGI paves the way | Oneindia News

In a move to pave the way for the availability of vaccines like Pfizer and Moderna in India, the Drugs Controller General of India (DCGI) has exempted foreign Covid-19 vaccines approved by specific nations or health bodies from post-approval bridging trials in the country. #Pfizer #Moderna #Covid19Vaccine

Credit: Oneindia    Duration: 02:05Published
Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen [Video]

Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen

From DCGI approving new anti-Covid drug, to health ministry issues new rules for hospital admissions, here are the top updates on the coronavirus. DCGI approved a new anti-Covid oral drug, which has been developed by DRDO and Dr. Reddy’s. The medicine has been given emergency use approval by DCGI. Meanwhile, Health Ministry said that a positive Covid-19 report is now not mandatory for a patient to be admitted to a hospital. Also, Supreme Court formed a 12-member National Task Force on medical oxygen. The new panel includes 10 doctors and 2 top bureaucrats from the Centre, who will ensure streamlined delivery of oxygen across India. Watch the full video for more updates on the pandemic.

Credit: HT Digital Content    Duration: 03:24Published
DCGI approves DRDO's anti-COVID drug helpful in faster recovery [Video]

DCGI approves DRDO's anti-COVID drug helpful in faster recovery

Drugs Controller General of India (DCGI) on May 08 approved emergency use DRDO's anti-COVID drug which the agency said will be helpful in faster recovery of hospitalised patients. While speaking to ANI, Institute of Nuclear Medicine and Allied Sciences (INMAS-DRDO) scientists spoken about drug 2-deoxy-D-glucose (2-DG). The drug will be of immense benefit to the people suffering from COVID-19.

Credit: ANI    Duration: 02:44Published

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Now, book COVID-19 vaccine appointment on Paytm - step by step details here

The application uses Co-WIN integration to gather data about vaccination centres. Users will need to register using their mobile number.
DNA

'Unprecedented and remarkable' change needed to derail 19 July 'terminus date' for COVID restrictions

19 July is the "terminus date" for England's remaining coronavirus restrictions and it would take an "unprecedented and remarkable" change in circumstances to..
Sky News

COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacy

Novavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.
DNA

Covid: Fresh cases fall to 76-day low, daily toll lowest in 2 months

The number of active cases of Covid-19 in India, which had swelled to over 37.2 lakh at the height of the second wave, has fallen below 10 lakh after 66 days.The..
IndiaTimes

You Might Like